- Home
- INSP
as 07-26-2024 4:00pm EST
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | GOLDEN VALLEY |
| Market Cap: | 4.0B | IPO Year: | 2018 |
| Target Price: | $244.29 | AVG Volume (30 days): | 458.1K |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $123.00 - $292.99 | Next Earning Date: | 08-06-2024 |
| Revenue: | $660,912,000 | Revenue Growth: | 41.71% |
| Revenue Growth (this year): | 28.64% | Revenue Growth (next year): | 20.80% |
Stock Insider Trading Activity of Inspire Medical Systems Inc. (INSP)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Buchholz Richard | INSP | Chief Financial Officer | Apr 17 '24 | Sell | $230.03 | 15,000 | $3,450,450.00 | 28,271 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $203.33 | 9,388 | $1,908,862.04 | 94,270 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $204.35 | 10,694 | $2,185,318.90 | 83,576 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $205.27 | 11,645 | $2,390,369.15 | 71,931 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $206.19 | 3,379 | $696,716.01 | 68,552 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $207.25 | 1,420 | $294,295.00 | 67,132 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $208.34 | 1,492 | $310,843.28 | 65,640 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $209.46 | 1,310 | $274,392.60 | 64,330 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $210.99 | 232 | $48,949.68 | 64,098 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $213.26 | 440 | $93,834.40 | 63,658 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $203.33 | 9,388 | $1,908,862.04 | 94,270 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $204.35 | 10,694 | $2,185,318.90 | 83,576 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $205.27 | 11,645 | $2,390,369.15 | 71,931 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $206.19 | 3,379 | $696,716.01 | 68,552 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $207.25 | 1,420 | $294,295.00 | 67,132 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $208.34 | 1,492 | $310,843.28 | 65,640 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $209.46 | 1,310 | $274,392.60 | 64,330 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $210.99 | 232 | $48,949.68 | 64,098 | SEC Form 4 |
| Herbert Timothy P. | INSP | CEO and President | Apr 1 '24 | Sell | $213.26 | 440 | $93,834.40 | 63,658 | SEC Form 4 |
| Griffin Jerry C | INSP | Director | Apr 1 '24 | Sell | $213.99 | 32 | $6,847.68 | 10,900 | SEC Form 4 |
| Griffin Jerry C | INSP | Director | Mar 25 '24 | Sell | $197.81 | 54 | $10,681.74 | 11,136 | SEC Form 4 |
| Griffin Jerry C | INSP | Director | Mar 25 '24 | Sell | $197.81 | 500 | $98,905.00 | 10,636 | SEC Form 4 |
| Rondoni John | INSP | Chief Technology Officer | Mar 22 '24 | Sell | $193.70 | 825 | $159,802.50 | 14,832 | SEC Form 4 |
| Rondoni John | INSP | Chief Technology Officer | Mar 22 '24 | Sell | $194.46 | 3,062 | $595,436.52 | 11,770 | SEC Form 4 |
| Rondoni John | INSP | Chief Technology Officer | Mar 22 '24 | Sell | $195.22 | 500 | $97,610.00 | 11,270 | SEC Form 4 |
Latest Inspire Medical Systems Inc. News
INSP Breaking Stock News: Dive into INSP Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
Zacks
4 days ago
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
Insider Monkey
4 days ago
Is This The Right Entry Point To Add Inspire Medical Systems (INSP)?
GlobeNewswire
5 days ago
Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
Medical Device Network
5 days ago
Inspire Medical secures CE Mark of MRI compatibility for Inspire IV device
MT Newswires
8 days ago
Inspire Medical Systems' Implantable Inspire IV Gains EU Approval for Full-Body MRI Compatibility
GlobeNewswire
8 days ago
Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation
GlobeNewswire
8 days ago
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
Compare INSP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INSP Inspire Medical Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.